Russia and China plan to launch a major pharmaceutical production facility
Russia and China have agreed to establish a new joint pharmaceutical venture. The project is valued at 13.06 billion tenge. This cooperation is aimed at strengthening drug security and expanding the availability of medicines in the markets of both countries.
The construction of the plant will be an important step in the development of bilateral economic relations. The new production facility will allow for the manufacturing of modern drugs that will meet international quality standards. Experts note that using Chinese technologies and Russian production capacities will help accelerate the process of import substitution in the medical sector.
The implementation of the project will also benefit the economy of the region where the plant will be located. It is expected to create new jobs for qualified specialists, such as pharmacists, engineers, and technologists. Furthermore, the launch of the enterprise will help reduce dependence on supplies of certain types of medicines from other countries.
In the near future, the parties will begin designing the facility and preparing the necessary documentation. It is expected that after the completion of all construction and commissioning work, the plant will begin full-scale operations. This project underscores the desire of Russia and China to develop a long-term partnership in the fields of high technology and healthcare.